Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina Usha K. PrasadDavid GrayHenry Purcell Review 02 March 2009 Pages: 127 - 137
Drug evaluation: Vildagliptin-metformin single-tablet combination Abd A. TahraniMilan K. PiyaAnthony H. Barnett Review 19 March 2009 Pages: 138 - 154
Telbivudine in the treatment of chronic hepatitis B Kathryn Nash Review 18 February 2009 Pages: 155 - 169
Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review Wim VerbeeckSiegfried TuinierGeertruida E. Bekkering Review 23 February 2009 Pages: 170 - 184
Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir+ritonavir regimens in the CASTLE study Kit N. SimpsonRukmini RajagopalanBirgitta Dietz Original Research 14 February 2009 Pages: 185 - 193
Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial Jean-Louis SelamLuigi F. Meneghini Original Research 02 March 2009 Pages: 194 - 207
Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab Alvaro P. C. LupinacciJorge I. CalzadaPeter A. Netland Original Research 20 February 2009 Pages: 208 - 216
Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy Maureen J. LageRosalind FabunmiDerek A. Misurski Original Research 14 February 2009 Pages: 217 - 229
Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist Andrew E. DenkerGaetano MorelliJohn A. Wagner Original Research 14 February 2009 Pages: 230 - 240
Dynamic splinting after treatment with botulinum toxin type-A: A randomized controlled pilot study Jenny M. LaiGerard E. FranciscoF. Buck Willis Original Research 04 February 2009 Pages: 241 - 248